Vous avez cherché: proteolytic (Anglais - Maltais)

proteolytic enzymes.
enżimi proteolytic.

proteolytic activity:
attività proteolitika:

concentrate of proteolytic enzymes enriched in bromelain
konċentrat ta’ enzimi proteolitiċi arrikkiti fi bromelain

nexobrid concentrate of proteolytic enzymes enriched in bromelain
nexobrid konċentrat ta’ enzimi proteolitiċi arrikkiti bi bromelain

lipegfilgrastim is metabolised via intra- or extracellular degradation by proteolytic enzymes.
lipegfilgrastim jiġi metabolizzat permezz ta’ degradazzjoni intra- jew extraċellulari minn enzimi proteolitiċi.

the biological activity of the various expected proteolytic degradation products has not been assessed.
l-attività bijoloġika mistennija tal-prodotti proteolitiċi varji tad- degradazzjoni ma kienitx evalwata.

after subcutaneous injection, proteolytic tissue enzymes degrade protamine to permit the absorption of insulin.
wara injezzjoni taħt il- ġilda, l-enzimi tat-tessut proteolitiku jiddegradaw il-protamine biex jippermettu l-assorbiment tal- insulina.

as with other large proteins elimination of rilonacept is expected to be via proteolytic catabolism and target mediated clearance.
bħal fil-każ ta’ proteini kbar oħrajn, l-eliminazzjoni ta’ rilonacept hi mistennija li tkun permezz ta’ kataboliżmu proteolitiku u tneħħija medjata mill-mira li trid tintlaħaq.

during clinical development, a total of 362 patients were treated with the concentrate of proteolytic enzymes enriched in bromelain.
matul l-iżvilupp kliniku, total ta’ 362 pazjent ġew ikkurati bil-konċentrat ta’ enzimi proteolitiċi arrikkiti fi bromelain.

hiv protease is an enzyme required for the proteolytic cleavage of the viral polyprotein precursors to the individual proteins found in infectious hiv.
il- protease ta ’ l- hiv hija enzima meħtieġa għall- qtugħ protejolitiku tal - prekursuri tal- poliproteini virali (proteolytic cleavage of the viral polyprotein precursors) għall - proteini individwali li jinsabu f’ hiv infettiva.

albiglutide is a protein for which the expected metabolic pathway is degradation to small peptides and individual amino acids by ubiquitous proteolytic enzymes.
albiglutide huwa proteina li r-rotta metabolika mistennija tiegħu hija d-degradazzjoni għal peptidi żgħar u aċidi amminiċi individwali permezz ta’ enzimi proteolitiċi preżenti kullimkien.

based on the proteolytic activity of ocriplasmin, preclinical and clinical findings, the potential for lens subluxation or phacodonesis cannot be ruled out.
abbażi tal-attività proteolitika ta’ ocriplasmin, sejbiet prekliniċi u kliniċi, il-potenzjal ta’ ċaqliq tal-lenti jew fakodonesi ma jistax ikun eskluż.

concentrate of proteolytic enzymes enriched in bromelain is systemically absorbed from burn wound areas (see section 5.2).
konċentrat ta’ enzimi proteolitiċi arrikkiti fi bromelain jiġi assorbit b’mod sistemiku minn żoni b’feriti kkawżati minn ħruq (ara sezzjoni 5.2).

binding of trastuzumab to her2 inhibits ligand-independent her2 signalling and prevents the proteolytic cleavage of its extracellular domain, an activation mechanism of her2.
twaħħil ta’ trastuzumab ma’ her2 jinibixxi sinjali ta’ her2 indipendenti mil-ligand u jipprevjeni l-qsim proteolitiku tad-dominju ekstraċellulari tiegħu, mekkaniżmu ta’ attivazzjoni ta’ her2.

blinatumomab mediates the formation of a cytolytic synapse between the t-cell and the tumour cell, releasing proteolytic enzymes to kill both proliferating and resting target cells.
blinatumomab jaġixxi ta’ medjatur fil-formazzjoni ta’ sinapsi ċitolitika bejn iċ-ċellula t u ċ-ċellula tat-tumur, u jirrilaxxa enzimi proteolitiċi biex joqtol kemm iċ-ċelluli fil-mira li jipproliferaw kif ukoll dawk inattivi.

as with other large proteins, both free and bound aflibercept, are expected to be cleared, more slowly, by other biological mechanisms, such as proteolytic catabolism.
bħal proteini kbar oħra, kemm l-aflibercept ħielsa u kemm dak marbut, huma mistennija li jitneħħew aktar bil-mod, permezz ta’ mekkaniżmi bijoloġiċi oħra, bħall- kataboliżmu proteolitiku.

carfilzomib is a tetrapeptide epoxyketone proteasome inhibitor that selectively and irreversibly binds to the n terminal threonine containing active sites of the 20s proteasome, the proteolytic core particle within the 26s proteasome, and displays little to no activity against other protease classes.
carfilzomib huwa inibitur ta’ tetrapeptide epoxyketone proteasome li jorbot b’mod selettiv u irriversibbli mal-n terminal threonine li fih siti attivi tal-20s proteasome, il-partiċella b’qalba proteolitika fit-26s proteasome, u juri ftit li xejn sa xejn affattu attività kontra klassijiet oħra ta’ protease.

the metabolism and elimination of bevacizumab is similar to endogenous igg i.e. primarily via proteolytic catabolism throughout the body, including endothelial cells, and does not rely primarily on elimination through the kidneys and liver.
il-metaboliżmu u l-eliminazzjoni ta’ bevacizumab huma simili għal igg endoġenu i.e. primarjament permezz ta’ kataboliżmu proteolitiku mal-ġisem kollu, inkluż ċelluli ta’ l-endotilju, u ma jiddependix primarjament minn eliminazzjoni mill-kliewi u l-fwied.

in a biochemical assay, simeprevir inhibited the proteolytic activity of recombinant genotype 1a and 1b hcv ns3/4a proteases, with median ki values of 0.5 nm and 1.4 nm, respectively.
f’analiżi bijokimika, simeprevir impedixxa l-attività proteolitika ta’ ġenotip 1a u 1b ta’ hcv ns3/4a proteases rikombinanti, b’valuri ki medjani ta’ 0.5 nm u 1.4 nm rispettivament.

following passage into the systemic circulation, ziconotide is expected to be primarily susceptible to proteolytic cleavage by various ubiquitous peptidases/proteases present in most organs (e.g., kidney, liver, lung, muscle, etc.), and thus degraded to peptide fragments and its individual constituent free amino acids.
wara li jgħaddi għal ġoċ- ċirkolazzjoni sistemika, ziconotide hu mistenni li jkun primarjament suxxettibbli għal cleavage proteolitiku minn peptidases/proteases varji li huma preżenti kullimkien fil-biċċa l-kbira ta’ l-organi (eż., kliewi, fwied, pulmun, muskoli, eċċ.), u għaldaqstant iddegrada għal frak tal-peptides u l-amino acids liberi kostitwenti individwali tiegħu.